Hypericum perforatum to improve post-operative Pain Outcome after monosegmental Spinal microdistectomy

INTERVENTION: Trade Name: Hypericum perforatum C200 Product Name: Hypericum perforatum C 200 Product Code: 2502726 Pharmaceutical Form: Pillules Pharmaceutical form of the placebo: Pessary Route of administration of the placebo: Oral use CONDITION: Post‐op pain Outcome after monosegmental Spinal microdistectomy Therapeutic area: Diseases [C] ‐ Musculoskeletal Diseases [C05] PRIMARY OUTCOME: Main Objective: Post‐op pain measured on a 100 mm VAS on the 3rd day postOP Primary end point(s): Post‐op pain reduction measured on a 100 mm VAS on the 3rd day postOP compared to baseline Secondary Objective: postOP use of analgetic medication Timepoint(s) of evaluation of this end point: 3rd day postOP SECONDARY OUTCOME: Secondary end point(s): reduction of postOP use of analgetic medication Timepoint(s) of evaluation of this end point: 5th day postOP INCLUSION CRITERIA: monosegmental spinal microdistectomy the day before Age between 18 and 75 Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18‐64 years) yes F.1.2.1 Number of subjects for this age range 100 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 100